The Global Fund is working to increase access to all the needed World Health Organization-recommended antiretroviral medicines (ARVs) and formulations at the optimum price while simultaneously maintaining a sustainable competitive market. We have framework agreements with a number of manufacturers to ensure prices and availability, based on anticipated market demand.
Documents related to our strategy, past tenders and reference prices are available for download here.
The Global Fund's Market Shaping Strategy was approved in May 2011 and directs the Global Fund to "secure the pediatric ARV market" by adopting a coordinated approach to the procurement of pediatric ARVs in the fight against HIV/AIDS.
The ARV Procurement Working Group was established in September 2011 with a focus on the procurement of pediatric ARVs. Since 2016, this group has evolved its scope to include ARVs for adolescents and adults. It is comprised of diverse partners and stakeholders organized into two inter-linked groups: the ARV Procurement Working Group and the Procurement Consortium.
The ARV Procurement Working Group is the umbrella group including all stakeholders and partners of various interests and mandates in supporting the collective efforts toward securing the ARV market. The working group is chaired by the Global Fund and includes:
The working group observers are:
The Procurement Consortium is a sub-set of the working group focusing on the alignment and coordination of procurement operational activities. The consortium aims to achieve the coordinated procurement approach defined and agreed upon by the ARV Procurement Working Group.
Documents from the working group are available here for download.